Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers

Completed

Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine the safety and efficacy of an investigational antiarrhythmic drug (ATI-2042) in the treatment of atrial fibrillation in patients with a dual chamber pacemaker.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 March 2009.

1 Jul 2006 17 Oct 2006 1 Dec 2008 1 Dec 2008 1 Mar 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Study Director: Olga Bandman, MD ARYx Therapeutics

    EzekowitzM@mlhs.org